JP2006131633A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006131633A5 JP2006131633A5 JP2005320134A JP2005320134A JP2006131633A5 JP 2006131633 A5 JP2006131633 A5 JP 2006131633A5 JP 2005320134 A JP2005320134 A JP 2005320134A JP 2005320134 A JP2005320134 A JP 2005320134A JP 2006131633 A5 JP2006131633 A5 JP 2006131633A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- compound
- formula
- inhibits
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 230000032683 aging Effects 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 3
- 210000000434 stratum corneum Anatomy 0.000 claims 3
- 108091005771 Peptidases Proteins 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 210000003491 Skin Anatomy 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 102000033147 ERVK-25 Human genes 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000035443 Peptidases Human genes 0.000 claims 1
- 102000013566 Plasminogen Human genes 0.000 claims 1
- 108010051456 Plasminogen Proteins 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 230000002378 acidificating Effects 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000002797 proteolythic Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Claims (6)
- 少なくとも１種の以下の式（Ｉ）の化合物
Ｒ１、Ｒ２、Ｒ３およびＲ４はそれぞれ、互いに独立に、水素原子、Ｃ１〜Ｃ４アルキル基、または１〜５個のヒドロキシル基を含むことができるＣ２〜Ｃ６ヒドロキシアルキル基を表し、Ｒ１からＲ４基の少なくとも１つはヒドロキシアルキル基を表す］、ならびにこれらの塩、これらの溶媒和物およびこれらの異性体のみからなる、皮膚および／または粘膜の老化の徴候を防止するおよび／または軽減する薬剤。 - 前記式（Ｉ）の化合物が、角質層のタンパク質分解酵素の活性を刺激することを特徴とする、請求項１に記載の薬剤。
- 前記式（Ｉ）の化合物が、角質層の酸性プロテアーゼの活性を刺激することを特徴とする、請求項１または２に記載の薬剤。
- 前記式（Ｉ）の化合物が、表皮の分化を調節する、および／または、加齢に関連する角質層中の遊離アミノ酸量の減少を阻害する、および／または、加齢に関連する異常タンパク質の蓄積を減少させることを特徴とする、請求項１から３のいずれか一項に記載の薬剤。
- 請求項１から４のいずれか一項に記載の薬剤と、有害なプロテアーゼの活性を低下させるおよび／または阻害する少なくとも１種の薬剤とを含む、皮膚および／または粘膜の老化の徴候を防止する、および／または軽減するための、化粧品組成物および／または皮膚用組成物。
- 請求項１から４のいずれか一項に記載の薬剤と、ＭＭＰを阻害する少なくとも１種の薬剤および／またはプラスミノーゲンの活性化を阻害する少なくとも１種の薬剤とを含む、請求項５に記載の化粧品組成物および／または皮膚用組成物。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0411783A FR2877220B1 (fr) | 2004-11-04 | 2004-11-04 | Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006131633A JP2006131633A (ja) | 2006-05-25 |
| JP2006131633A5 true JP2006131633A5 (ja) | 2008-12-18 |
Family
ID=34950464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005320134A Pending JP2006131633A (ja) | 2004-11-04 | 2005-11-02 | 皮膚の老化の徴候を抑制する尿素化合物の使用 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1674072B1 (ja) |
| JP (1) | JP2006131633A (ja) |
| CA (1) | CA2524653A1 (ja) |
| ES (1) | ES2492915T3 (ja) |
| FR (1) | FR2877220B1 (ja) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2902999B1 (fr) | 2006-07-03 | 2012-09-28 | Oreal | Utilisation de derives c-glycoside a titre d'actif prodesquamant |
| US20100028471A1 (en) * | 2006-09-20 | 2010-02-04 | Chanel Parfums Beaute | Cosmetic use of active agents that stimulate matriptase expression |
| FR2918269B1 (fr) | 2007-07-06 | 2016-11-25 | Oreal | Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses. |
| FR2918561B1 (fr) | 2007-07-09 | 2009-10-09 | Oreal | Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage. |
| FR2918563B1 (fr) | 2007-07-12 | 2009-12-04 | Oreal | Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire. |
| FR2924613B1 (fr) * | 2007-12-10 | 2012-12-21 | Oreal | Utilisation cosmetique de proteines de type hsp27. |
| FR2925314B1 (fr) * | 2007-12-19 | 2012-11-23 | Oreal | Utilisation cosmetique de proteines de type transglutaminase 3 |
| FR2931064B1 (fr) | 2008-05-14 | 2010-08-13 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane |
| FR2936706B1 (fr) | 2008-10-08 | 2010-12-17 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane |
| FR2939036B1 (fr) | 2008-12-01 | 2010-12-17 | Oreal | Procede de coloration artificielle de la peau utilisant un melange de carotenoide et de colorant vert lidophile ; nouveau melange de colorants lipophiles ; composition |
| FR2940609B1 (fr) | 2008-12-30 | 2011-05-06 | Oreal | Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique |
| FR2940612B1 (fr) | 2008-12-30 | 2011-05-06 | Oreal | Association de monosaccharides avec l'acide ascorbique et son utilisation en cosmetique |
| FR2940613B1 (fr) | 2008-12-30 | 2012-09-21 | Oreal | Association de monosaccharides avec des filtres solaires et son utilisation en cosmetique |
| FR2940610B1 (fr) | 2008-12-30 | 2011-05-06 | Oreal | Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique |
| FR2940611B1 (fr) | 2008-12-30 | 2012-01-13 | Oreal | Association de monosaccharides et d'adenosine et son utilisation en cosmetique |
| FR2940608B1 (fr) | 2008-12-30 | 2011-04-22 | Oreal | Utilisation de monosaccharides et composition |
| FR2940615B1 (fr) | 2008-12-30 | 2011-12-30 | Oreal | Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique |
| WO2011073576A2 (fr) | 2009-12-18 | 2011-06-23 | L'oreal | Procede de coloration de la peau impliquant un compose apte a condenser in situ et un agent colorant de la peau |
| FR2960773B1 (fr) | 2010-06-03 | 2015-12-11 | Oreal | Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether |
| FR2979540B1 (fr) | 2011-09-06 | 2013-12-27 | Oreal | Association de carraghenane et de c-glycoside et leurs utilisations |
| MX2016016218A (es) * | 2014-06-17 | 2017-02-23 | Procter & Gamble | Composicion para la reduccion del cabello encrespado. |
| US10632054B2 (en) | 2015-04-02 | 2020-04-28 | The Procter And Gamble Company | Method for hair frizz reduction |
| CN108883038B (zh) | 2016-04-01 | 2022-04-12 | 宝洁公司 | 用于快速干燥毛发的组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2703185A1 (de) * | 1977-01-27 | 1978-08-10 | Henkel Kgaa | Kosmetische mittel mit einem gehalt an haut-feuchthaltemitteln |
| EP0585130B1 (en) * | 1992-08-27 | 1998-01-28 | Shiseido Company Limited | External preparation for skin containing a depigmentation agent |
| CA2281944C (en) * | 1997-02-25 | 2007-05-15 | The Regents Of The University Of Michigan | Methods and compositions for preventing and treating chronological aging in human skin |
| JP2004075661A (ja) * | 2002-06-18 | 2004-03-11 | Shiseido Co Ltd | 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法 |
| FR2848116B1 (fr) * | 2002-12-10 | 2007-01-05 | Nuxe Lab | Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide. |
-
2004
- 2004-11-04 FR FR0411783A patent/FR2877220B1/fr not_active Expired - Fee Related
-
2005
- 2005-10-27 CA CA002524653A patent/CA2524653A1/fr not_active Abandoned
- 2005-11-02 JP JP2005320134A patent/JP2006131633A/ja active Pending
- 2005-11-03 ES ES05292332.3T patent/ES2492915T3/es active Active
- 2005-11-03 EP EP05292332.3A patent/EP1674072B1/fr active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006131633A5 (ja) | ||
| UA100966C2 (ru) | Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей | |
| BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| JP2006117700A5 (ja) | ||
| RS51213B (sr) | Farmaceutski vaginalni gel koji sadrži tenofovir | |
| RS51764B (en) | TRANSDERMAL PHARMACEUTICAL COMPOSITION | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| ES2330291A1 (es) | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| BR0009043A (pt) | Composto, composição farmacêutica, e, método de tratar uma doença em um animal em que a atividade da cisteìna protease contribui para a patologia e/ou sintomatologia da doença | |
| DE502005007791D1 (de) | Wässrige antitranspirant formulierung | |
| ATE446313T1 (de) | Muteine von tränen-lipocalin | |
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| ES2593040T3 (es) | Utilización de compuestos de urea para favorecer la descamación | |
| EP1614675A3 (en) | Amino acids with affinity for the alpha-2-delta protein | |
| WO2007021886A3 (en) | Truncated memapsin 2 for use for treating alzheimer's disease | |
| EP1816122A3 (en) | 3,4,5-substituted piperidines as therapeutic compounds | |
| SE0002202D0 (sv) | New peptides | |
| CA2494473A1 (en) | Stabilized protein compositions for topical administration and methods of making same | |
| ATE333451T1 (de) | Verwendung von nitrilenverbindungen als arztneimittel | |
| EP2308837A3 (en) | Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors | |
| PL1868631T3 (pl) | Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej | |
| DK1635776T5 (da) | Lipidoverf ringsproteinsystemer samt deres kosmetiske dermatologiske anvendelse | |
| ITMI20031396A1 (it) | Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante. | |
| ATE336226T1 (de) | Haarbehandlungszusammensetzungen mit xanthin und alpha-hydroxysäure |